Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (05): 81-86    DOI:
    
Establishment of High Throughput Screening System of mGluR5
SHI Liu1,2,JIANG Ya-qin1,2,BAI Yan-qiu1,2
1.Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300, China
2.Graduate University of the Chinese Academy of Sciences, Beijing 100039, China
Download: HTML   PDF(904KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: A high throughput screening system of mGluR5 was established by Ca2+ mobilization detecting method. Methods: The human mGluR5 cDNA was cloned using gene synthesis technique and subcloned into the pCNDA3.1 mammalian expression vector. The recombinant plasmid was then transfected into HEK293 cells. The transfected cells were stably selected by G418. Single cell clones with high Ca2+ inducibility and low background were isolated. Results: Assay conditions were optimized, under which more robust signals were observed. Further validation results indicated that in this mGluR5 cell line, the potencies of mGluR5 agonists, antagonists were comparable with the published data. The rank order of agonists potency for mGluR5 was L-Quisqualic acid (EC50=67.8nM) > L-Glu (EC50=2.73μM). The rank order of antagonists potency for mGluR5 was MTEP (IC50=3.3nM) >Fenobam (IC50=23.5nM). The cell line was stable for at least 15 passages. The results of functional assay indicated that a HTS system for mGluR5 antagonist screening had been established successfully with a Z’ Prime of 0.68.By using this assay system, several positive compounds were identified which represented strong inhibition effect. Conclusion: The recombinant cell model is suitable for mGluR5 receptor targeted high throughput screening.



Key wordsMetabotropic Glutamate Receptor 5 (mGluR5)      high throughput screening (HTS)      agonist/antagonist     
Received: 23 December 2009      Published: 25 May 2010
Corresponding Authors: Liu Shi     E-mail: shiliu@hdbiosciences.com
Cite this article:

DAN Liu, JIANG E-Qin, BAI Yan-Qiu. Establishment of High Throughput Screening System of mGluR5. China Biotechnology, 2010, 30(05): 81-86.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I05/81

[1] O’Brien J A, Lemaire W, Chen T B,et al.A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol Pharmacol, 2003, 64(3):731740. 
[2] Lavreysen H,Poul E L,Gompel P V,et al.Supersensitivity of human metabotropic glutamatela receptor signaling in L929sA cell.Mol Pharmacol 2002,61(5):12441254. 
[3] Kouhen O E,Lehto S J,Pan J B,et al.Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A841720, a novel noncompetitive mGluR1 receptor antagonist.British Journal of Pharmacology.2006,149:761774. 
[4] Abe T,Sugihara H,Nawa H,et al.Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+signal transduction.The Journal of Biological Chemistry,1992,267(19):1336113368. 
[5] Watkins J C,Jane D E.The glutamate story.British Journal of Pharmacology,2006,147 Suppl 1:S100S108. 
[6] Gass J T,Osborne M P,Watson N L,et al.mGluR5 antagonism attenuates methamphetamine renforcement and prevents reinstatement of methamphetamineseeking behavior in rat.Neuropsychopharmacology,2009,34(4):820833. 
[7] Bckstrm P,Hyyti P.Ionotropic and metabotropic glutamate receptor antagonism attenuates cueinduced cocaine seeking.Neuropsychopharmacology,2006,31(4):778786. 
[8] Ayala J E,Chen Y,Banko J L,et al. mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology,2009,34(9):20572071. 
[9] 曹婧,张烨,彭志刚.组胺H3受体激活剂高通量筛选细胞模型的研究.中国生物工程杂志,2008,28(9):6167. Cao J, Zhang Y, Peng Z G. China Biotechnology,2008,28(9):6167. 
[10] 张巨,程杰,陈静.HepG2/mdr1稳定细胞系的建立及特性研究.中国生物工程杂志,2009,29(5):1722. Zhang J, Cheng J, Chen J. China Biotechnology,2009,29(5):1722. 
[11] 张娅玲,白艳秋.代谢性谷氨酸受体4亚型(mGluR4)高通量药物筛选模型的建立.生物工程学报,2009,25(3):457463. Zhang Y L, Bai Y Q. Chinese Journal of Biotechnology,2009,25(3):457463. 
[12] Mutel V,Ellis G J,Adam G,etal.Characterization of [3H]quisqualate binding to recombinant rat metabotropic glutamate la and 5a receptors and to rat and human brain sections.Journal of Neurochemistry,2000,75(6):25902601. 
[13] Porter R H, Jaeschke G, Spooren W,et al. Fenoban:a clinically validated nonbenzodiazepine anxiolytic is a potent,selective,and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.J Pharmacol,2005,315(2):711721. 
[14] Zhang J H,Chuang T D,Oldenburg K R.A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening,1999,4(2):6773. 
[15] Hemstapat K,Paulis T D,Chen Y L,et al.A novel class of positive allosteric modulators of mGluR1 interact with a site distinct from that of negative allosteric modulators.Molecular Pharmacology. 2006 ,70(2):616626.

No related articles found!